Roadmap to control HBV and HDV epidemics in China

doi:10.1016/j.jtbi.2017.04.007

Title: Roadmap to control HBV and HDV epidemics in China

Abstract

Hepatitis B virus (HBV) is endemic in China. Almost 10% of HBV infected individuals are also infected with hepatitis D virus (HDV) which has a 5–10 times higher mortality rate than HBV mono-infection. The aim of this manuscript is to devise strategies that can not only control HBV infections but also HDV infections in China under the current health care budget in an optimal manner. Furthermore, using a mathematical model, an annual budget of 10 billion dollars was optimally allocated among five interventions namely, testing and HBV adult vaccination, treatment for mono-infected and dually-infected individuals, second line treatment for HBV mono-infections, and awareness programs. As a result, we determine that the optimal strategy is to test and treat both infections as early as possible while applying awareness programs at full intensity. Under this strategy, an additional 19.8 million HBV, 1.9 million HDV infections and 0.25 million lives will be saved over the next 10 years at a cost-savings of 79 billion dollars than performing no intervention. Introduction of second line treatment does not add a significant economic burden yet prevents 1.4 million new HBV infections and 15,000 new HDV infections. In conclusion, test and treatment programs are highly efficient inmore »« less

Authors:

Goyal, Ashish ^[1]; Murray, John M. ^[1]

UNSW Australia, Sydney, NSW (Australia)

Publication Date:: 2017-04-23

Research Org.:: Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

Sponsoring Org.:: National Institutes of Health (NIH); USDOE

OSTI Identifier:: 1358168

Report Number(s):: LA-UR-16-28585
Journal ID: ISSN 0022-5193

Grant/Contract Number:: AC52-06NA25396

Resource Type:: Accepted Manuscript

Journal Name:: Journal of Theoretical Biology

Additional Journal Information:: Journal Volume: 423; Journal Issue: C; Journal ID: ISSN 0022-5193

Publisher:: Elsevier

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES; biological science; health economics; epidemiology; public policy; sexually transmitted infection

Citation Formats


                    Goyal, Ashish, and Murray, John M. Roadmap to control HBV and HDV epidemics in China.  United States: N. p., 2017. 
        Web.  doi:10.1016/j.jtbi.2017.04.007.

Copy to clipboard


                    Goyal, Ashish, & Murray, John M. Roadmap to control HBV and HDV epidemics in China.  United States.  doi:10.1016/j.jtbi.2017.04.007.

Copy to clipboard


                    Goyal, Ashish, and Murray, John M. Sun .  
        "Roadmap to control HBV and HDV epidemics in China".  United States.  doi:10.1016/j.jtbi.2017.04.007.  https://www.osti.gov/servlets/purl/1358168.

Copy to clipboard


                    
@article{osti_1358168,

  title        = {Roadmap to control HBV and HDV epidemics in China},

  author       = {Goyal, Ashish and Murray, John M.},

  abstractNote = {Hepatitis B virus (HBV) is endemic in China. Almost 10% of HBV infected individuals are also infected with hepatitis D virus (HDV) which has a 5–10 times higher mortality rate than HBV mono-infection. The aim of this manuscript is to devise strategies that can not only control HBV infections but also HDV infections in China under the current health care budget in an optimal manner. Furthermore, using a mathematical model, an annual budget of 10 billion dollars was optimally allocated among five interventions namely, testing and HBV adult vaccination, treatment for mono-infected and dually-infected individuals, second line treatment for HBV mono-infections, and awareness programs. As a result, we determine that the optimal strategy is to test and treat both infections as early as possible while applying awareness programs at full intensity. Under this strategy, an additional 19.8 million HBV, 1.9 million HDV infections and 0.25 million lives will be saved over the next 10 years at a cost-savings of 79 billion dollars than performing no intervention. Introduction of second line treatment does not add a significant economic burden yet prevents 1.4 million new HBV infections and 15,000 new HDV infections. In conclusion, test and treatment programs are highly efficient in reducing HBV and HDV prevalence in the population. Under the current health budget in China, not only test and treat programs but awareness programs and second line treatment can also be implemented that minimizes prevalence and mortality, and maximizes economic benefits.},

  doi          = {10.1016/j.jtbi.2017.04.007},

  journal      = {Journal of Theoretical Biology},

  number       = C,

  volume       = 423,

  place        = {United States},

  year         = {2017},

  month        = {4}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (DOE)

Publisher's Version of Record

DOI: 10.1016/j.jtbi.2017.04.007

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Works referencing / citing this record:

Application and Optimal Control for an HBV Model with Vaccination and Treatment
journal, September 2018

Zhang, Jing; Zhang, Suxia
Discrete Dynamics in Nature and Society, Vol. 2018
DOI: 10.1155/2018/2076983

Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil
journal, September 2018

Goyal, Ashish; Romero-Severson, Ethan Obie
PLOS ONE, Vol. 13, Issue 9
DOI: 10.1371/journal.pone.0203831

Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies
journal, April 2018

Zhu, Bin; Liu, Jinlin; Fu, Yang
International Journal of Environmental Research and Public Health, Vol. 15, Issue 4
DOI: 10.3390/ijerph15040661

Similar Records in DOE PAGES and OSTI.GOV collections:

Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil

Journal Article Goyal, Ashish ; Romero-Severson, Ethan Obie - PLoS ONE

Hepatitis D virus (HDV), which requires the presence of hepatitis B virus (HBV), is a deadly yet neglected disease that rapidly leads to liver cancer and disease-induced mortality. This co-dependence creates complex transmission dynamics that make it difficult to predict the efficacy of interventions aimed at HBV and/or HDV control in endemic regions, such as certain municipalities of Brazil, where up to 65% of HBV-infected persons are co-infected. We created a mathematical model that captures the joint transmission dynamics of HBV and HDV, incorporating mother-to-child, sexual and household transmission. With an aim to minimize the number of total infections andmore »« less
DOI: 10.1371/journal.pone.0203831

Full Text Available
Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs

Journal Article Huang, Hai ; Zhou, Wei ; Zhu, Haiyan ; ... - Toxicology and Applied Pharmacology

Background: Although current antiviral treatments (nucleoside analogs, NAs) for chronic hepatitis B virus (HBV) infection are effective in suppressing HBV-DNA replication, their clinical outcomes can be compromised by the increasing drug resistance and the inefficiency in promoting HBsAg/HBeAg seroconversion. Objectives: In this study, we will explore possible effects and mechanism of a natural product baicalin (BA) with the anti-HBV efficacy of entecavir (ETV), a first-line anti-HBV drug, in HBV-DNA, HBsAg/HBeAg seroconversion and drug-resistance. Methods: The co-effects of BA and ETV were conducted in wild-type/NA-resistance mutant HBV cell lines and DHBV-infected duckling models. HBV-DNA/RNAs, HBsAg/HBeAg, host factors (hepatocyte nuclear factors) weremore »« less
DOI: 10.1016/J.TAAP.2017.03.016
Blocking peptides against HBV: PreS1 protein selected from a phage display library

Journal Article Wang, Wei ; Liu, Yang ; Zu, Xiangyang ; ... - Biochemical and Biophysical Research Communications

Highlights: {yields} Successfully selected specific PreS1-interacting peptides by using phage displayed library. {yields} Alignment of the positive phage clones revealed a consensus PreS1 binding motif. {yields} A highly enriched peptide named P7 had a strong binding ability for PreS1. {yields} P7 could block PreS1 attachment. -- Abstract: The PreS1 protein is present on the outermost part of the hepatitis B virus (HBV) surface and has been shown to have a pivotal function in viral infectivity and assembly. The development of reagents with high affinity and specificity for PreS1 is of great significance for early diagnosis and treatment of HBV infection.more »« less
DOI: 10.1016/J.BBRC.2011.08.014
Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics

Journal Article Perelson, Alan S. ; Ke, Ruian - Clinical Pharmacology and Therapeutics

Modern viral kinetic modeling and its application to therapeutics is a field that attracted the attention of the medical, pharmaceutical and modeling communities during the early days of the AIDS epidemic. Its successes lead to applications of modeling methods not only to HIV but a plethora of other viruses, such as hepatitis C virus (HCV), hepatitis B virus (HBV) and cytomegalovirus (CMV), which along with HIV cause chronic diseases, and viruses such as influenza, respiratory syncytial virus (RSV), West Nile virus (WNV), Zika virus, and SAR-CoV-2, which generally cause acute infections. Here we first review the historical development of mathematicalmore »« less
DOI: 10.1002/cpt.2160
The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans

Journal Article Goyal, Ashish ; Ribeiro, Ruy Miguel ; Perelson, Alan S. - Viruses

Around 90–95% of hepatitis B virus (HBV) infected adults do not progress to the chronic phase and, instead, recover naturally. The strengths of the cytolytic and non-cytolytic immune responses are key players that decide the fate of acute HBV infection. In addition, it has been hypothesized that proliferation of infected cells resulting in uninfected progeny and/or cytokine-mediated degradation of covalently closed circular DNA (cccDNA) leading to the cure of infected cells are two major mechanisms assisting the adaptive immune response in the clearance of acute HBV infection in humans. We employed fitting of mathematical models to human acute infection datamore »« less
Cited by 4
DOI: 10.3390/v9110350

Full Text Available

Similar Records

Title: Roadmap to control HBV and HDV epidemics in China

Abstract

Citation Formats

Application and Optimal Control for an HBV Model with Vaccination and Treatment journal, September 2018

Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil journal, September 2018

Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies journal, April 2018

Application and Optimal Control for an HBV Model with Vaccination and Treatment
journal, September 2018

Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil
journal, September 2018

Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies
journal, April 2018